EGFR-AKT-Smad Signaling Promotes Formation of Glioma Stem-like Cells and Tumor Angiogenesis by ID3-Driven Cytokine Induction
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Aberrant activation of receptor tyrosine kinases (RTK) is causally linked to the pathobiological traits of glioblastoma and genesis of glioma stem-like cells (GSC), but the underlying mechanism is still unknown. Here, we show that epidermal growth factor receptor (EGFR) signaling regulates the proliferation, angiogenesis, and acquisition of GSC characteristics by inducing inhibitor of differentiation 3 (ID3) and ID3-regulated cytokines [GRO1 and interleukins (IL)-6 and 8] induction. We found that EGFR-mediated ID3 expression was regulated by Smad5, which was directly phosphorylated by AKT. Furthermore, ID3 alone imparted GSC features to primary astrocytes derived from Ink4a/Arf-deficient mouse, and EGFR–ID3–IL-6 signaling axis gave rise to tumor cell heterogeneity. Conversely, EGFR inhibitors suppressed EGFR-AKT-Smad5–driven induction of ID3, which led to a decrease in the tumorsphere forming ability of GSCs and U87MG cells that possess an active mutant EGFR, EGFRvIII, without obvious cytotoxic effects. However, these cells seemed to regain colonogenic ability after removal of the EGFR inhibitors. Together, the results delineate a novel integrative molecular mechanism in which the RTK-ID signaling pathway governs genesis and maintenance of GBM histopathologic features, such as GSCs-based tumor initiation, progression, and angiogenesis. Cancer Res; 71(22); 7125–34. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442 · cited 1×
“Although EGFR activation by overexpression or mutation is a common oncogenic event in more than 50% of patients with GBM, only 10% to 20% of these patients responded to EGFR inhibitors in a clinical trial (35).”
Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., Ceccarelli, C., Santini, D., Paterini, P., Marcu, K. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32533 · Cited by 779
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R. D., Engh, J., Iwama, T., Kunisada, T., Kassam, A. B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.252 · Cited by 656 · cited 8×
“, Page 10 To further characterize the EGFR-ID3 signaling pathway in GSC biology, three different GSCs, X01, X02 and X03 (14), were used.”
BackgroundMethodInfluentialCharles, N., Ozawa, T., Squatrito, M., Bleau, A.-M., Brennan, C. W., Hambardzumyan, D., & Holland, E. C. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.01.001 · Cited by 550 · cited 1×
“Glioma angiogenesis provides a perivasculature niche that allows GSCs to maintain their stemness (21, 22).”
BackgroundOncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422 · cited 1×
“In agreement with previous reports (25, 26), EGFRL858R, H-Ras, and bFGF increased IL-6 secretion, as did EGF treatment and overexpression of ID3 and EGFRvIII (Supplementary Fig.”
The Id proteins and angiogenesis
Benezra, R., Rafii, S., & Lyden, D. (2001) · Oncogene · doi:10.1038/sj.onc.1205160 · Cited by 222 · cited 1×
“To determine a possible role of ID3 in angiogenesis (23) and tumor cell heterogeneity, cytokine/chemokine secretion was measured by a custom angiogenesis cytokine antibody array in U87MGID3 and control cells, and 3 cytokines were shown to be upregulated (both expression and secretion) by ID3 overexpression; growth-reg…”
Huang, W.-L., Yeh, H.-H., Lin, C.-C., Lai, W.-W., Chang, J.-Y., Chang, W.-T., & Su, W.-C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-309 · Cited by 86
Cited by
The ID proteins: master regulators of cancer stem cells and tumour aggressiveness
Lasorella, A., Benezra, R., & Iavarone, A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3638 · Cited by 355
The Id-protein family in developmental and cancer-associated pathways
Roschger, C., & Cabrele, C. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-016-0161-y · Cited by 207
“The Id proteins also occur in cancer stem cells, for example in glioma stem-like cells (GSCs), where Id3 induction through the EGFR/Akt/Smad5 pathway leads to acquirement of GSCs characteristics and angiogenesis [197].”
BackgroundTwo mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
Li, X., Liu, Y., Granberg, K. J., Wang, Q., Moore, L. M., Ji, P., Gumin, J., Sulman, E. P., Calin, G. A., Haapasalo, H., et al. (2015) · Oncogene · doi:10.1038/onc.2014.98 · Cited by 99
EGFR and c-Met cross talk in glioblastoma and its regulation by human cord blood stem cells
Velpula, K. K., Dasari, V. R., Asuthkar, S., Gorantla, B., & Tsung, A. J. (2012) · Translational Oncology · doi:10.1593/tlo.12235 · Cited by 42
Huang, L., Cai, J., Guo, H., Gu, J., Tong, Y., Qiu, B., Wang, C., Li, M., Xia, L., Zhang, J., et al. (2019) · Hepatology · doi:10.1002/hep.30404 · Cited by 42
Metadata
- Authors
- Jin, X., Yin, J., Kim, S.-H., Sohn, Y.-W., Beck, S., Lim, Y. C., Nam, D.-H., Choi, Y.-J., & Kim, H.
- Venue
- Cancer Research
- Published
- 2011-11-13
- Volume
- 71
- Issue
- 22
- Pages
- 7125-7134
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2105279254
- Cited by
- 150
- References
- 9
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EGFR-AKT-Smad Signaling Promotes Formation of Glioma Stem-like Cells and Tumor Angiogenesis by ID3-Driven Cytokine Induction. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-1330
- The paper
- Jin, X., Yin, J., Kim, S.-H., Sohn, Y.-W., Beck, S., Lim, Y. C., Nam, D.-H., Choi, Y.-J., & Kim, H. (2011). EGFR-AKT-Smad Signaling Promotes Formation of Glioma Stem-like Cells and Tumor Angiogenesis by ID3-Driven Cytokine Induction. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-1330
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.